Skip to content


Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Home confinement ordered for ‘unhealthy’ Cosgrove

The former director of worldwide sales for Control Components Inc. was sentenced Thursday to 13 months home confinement and fined $20,000 for bribing Chinese officials.

Paul Cosgrove, 65, pleaded guilty in May to one count of violating the FCPA. He admitted authorizing bribes to employees at a Chinese state-owned facility to win business for CCI.

Since his guilty plea, Cosgrove’s health has deteriorated.

His chronic medical problems now include ‘heart disease, high blood pressure, diabetes, and sleep apnea that require consistent long-term monitoring and treatment by his doctors,’ according to medical records filed in court earlier this month.

His cardiologist said “each of Mr. Cosgrove’s health issues increase the risk that [he] will suffer another cardio or other life threatening event if not managed and treated vigilantly.”

As part of his plea deal in May, prosecutors said they would recommend a prison sentence of 15 months.

But in a filing last week, the DOJ said it would be satisfied with home confinement instead of prison because of Cosgrove’s health problems.

In addition to Cosgrove, six other former CCI executives have pleaded guilty to FCPA charges.

And in 2009, the company pleaded guilty to a three-count criminal information charging it with conspiracy to violate the FCPA and the Travel Act, and two substantive violations of the FCPA. It paid an $18.2 million criminal fine and retained a compliance monitor for three years.

Share this post


Comments are closed for this article!